Overall Technical outlook

Price Summary

NATCO Pharma Limited's shares increased 3.36% today, reflecting a outstanding day on the market.
On 2026-03-02, NATCO Pharma Limited's stock opened at 925.15, reached 967.85, hit a low of 925.15, and rose 3.36% to close at 956.25, with 1073075 shares traded.
The stock reached its highest price of 1035.1 and its lowest price of 746.5 during the 52-week period.
11 analysts estimate that the future price of NATCOPHARM will fall between 712.0 and 1480.0, with an average price expectation of approximately 970.36365.

Technicals


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
NATCOPHARM aroon db4f53
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance for NATCOPHARM, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
NATCOPHARM bbands db4f53
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR remains bullish, establishing a key support level that could help uphold the market's upward trajectory. This persistent bullish outlook suggests that the market may continue to rise, with the support providing a foundation for further gains.
NATCOPHARM psar db4f53
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The K-line has dropped below the D-line on the stochastic indicator while staying above 80, suggesting that a bearish price move may be beginning. This pattern indicates that the market's upward momentum is weakening, potentially leading to a reversal. Investors should stay alert for additional signs of a downturn.
NATCOPHARM stoch db4f53
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are currently aligned in a bearish pattern, indicating a downtrend. However, the slopes of the 20 and 50 SMAs are showing signs of wavering, suggesting that the bearish momentum for NATCOPHARM may be fading. This could signal a potential shift towards bullish price action, as the market's downward trajectory begins to lose strength and prepares for a possible reversal.
NATCOPHARM trippleSMA db4f53
Tripple SMA chart for NATCO Pharma Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.